MarketPeel
Insider Trading Intelligence
Pricing
…
MD

Mittie Doyle

AVTX
CHIEF MEDICAL OFFICER · AVALO THERAPEUTICS, INC. · CIK 0001918845
FILING MIX · LIFETIME40%/60%
BUYS
19
SELLS
28
TOTAL VALUE
$4.62M
COMPANIES
2
ACTIVE SINCE
Jul 2024
HOLDINGS NOW
73,557
AVG SELL PX
$19.49
TRADE KIND
SHOWING 47 / 47
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
9 backtested trades · 8 horizons · 39 pending
Forward-return performance of every backtestable P/S trade by Mittie Doyle, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d9+88.89%-7.75%+1.45%-9.20%-10.14%—
14d9+100.00%-19.19%+2.95%-17.28%-17.45%—
30d9+88.89%-21.63%+5.23%-27.79%-39.17%—
60d9(5 pending)+50.00%+4.79%+9.59%-1.71%+11.02%—
90d9(7 pending)+50.00%+3.70%+11.98%-8.28%-8.28%—
180d9(9 pending)——————
1y9(9 pending)——————
2y9(9 pending)——————
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AVTX · 51,776 shares · as of Jun 30, 2026
058,500117,000175,500234,00020252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 19 buys / 28 sellsCOVERAGE · 8 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AVTX
AVALO THERAPEUTICS, INC.
SALE
Chief Medical Officer
2,875——125,750Jun 30, 2026Jul 2, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
1,779$8.04$14.3K56,430Jun 30, 2026Jul 2, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
SALE
Chief Medical Officer
1,779——115,092Jun 30, 2026Jul 2, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
4,654$20.00$93.1K51,776Jun 30, 2026Jul 2, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
2,875$12.65$36.4K54,651Jun 30, 2026Jul 2, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,450$18.00$26.1K51,776Jun 23, 2026Jun 25, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
SALE
Chief Medical Officer
1,450——116,871Jun 23, 2026Jun 25, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
1,450$8.04$11.7K53,226Jun 23, 2026Jun 25, 2026 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
21,781——21,781Jun 16, 2026Jun 18, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
SALE
Chief Medical Officer
1,084$13.10$14.2K51,776Jun 10, 2026Jun 12, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
679$8.04$5.5K47,801May 28, 2026Jun 1, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
SALE
Chief Medical Officer
679——118,321May 28, 2026Jun 1, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
679$16.00$10.9K47,122May 28, 2026Jun 1, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
43,500——47,122May 21, 2026May 26, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
3,000$12.65$38.0K6,622May 15, 2026May 19, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,000$18.76$56.3K3,622May 15, 2026May 19, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
SALE
Chief Medical Officer
3,000——128,625May 15, 2026May 19, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
27,538$18.03$496.4K82,639May 6, 2026May 7, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
44,944$21.20$952.7K32,695May 6, 2026May 7, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
19,015$22.41$426.1K13,680May 6, 2026May 7, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
10,058$22.88$230.1K3,622May 6, 2026May 7, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,000$19.65$98.3K77,639May 6, 2026May 7, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
77,905$12.65$985.5K81,527May 6, 2026May 7, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
SALE
Chief Medical Officer
28,650——119,000May 6, 2026May 7, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
28,650$8.04$230.3K110,177May 6, 2026May 7, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
SALE
Chief Medical Officer
77,905——131,625May 6, 2026May 7, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,679$16.00$26.9K3,622May 5, 2026May 7, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
1,000$12.65$12.7K4,622May 5, 2026May 7, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
SALE
Chief Medical Officer
679——147,650May 5, 2026May 7, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
679$8.04$5.5K5,301May 5, 2026May 7, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
SALE
Chief Medical Officer
1,000——209,530May 5, 2026May 7, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
3,970$12.65$50.2K7,592Apr 6, 2026Apr 8, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
SALE
Chief Medical Officer
3,970——210,530Apr 6, 2026Apr 8, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,970$18.01$71.5K3,622Apr 6, 2026Apr 8, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
679$16.00$10.9K3,622Apr 1, 2026Apr 3, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
SALE
Chief Medical Officer
679——148,329Apr 1, 2026Apr 3, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
679$8.04$5.5K4,301Apr 1, 2026Apr 3, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
19,500$12.65$246.7K23,122Mar 16, 2026Mar 18, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
SALE
Chief Medical Officer
19,500——214,500Mar 16, 2026Mar 18, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
25,492$16.15$411.6K3,622Mar 16, 2026Mar 18, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
SALE
Chief Medical Officer
5,992——149,008Mar 16, 2026Mar 18, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
5,992$8.04$48.2K29,114Mar 16, 2026Mar 18, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
105,000——105,000Feb 26, 2026Mar 2, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
SALE
Chief Medical Officer
1,013$4.10$4.2K3,622Dec 10, 2025Dec 12, 2025 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
79,456——79,456Aug 7, 2025Aug 8, 2025 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
155,000——155,000Jan 28, 2025Jan 30, 2025 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
234,000——234,000Jul 15, 2024Jul 16, 2024 ↗View →
Other insiders · AVTX
Loading peer insiders…
About this filer
CIK 0001918845
ROLE
Chief Medical Officer
PRIMARY
AVTX
COMPANIES
2
ACTIVE SINCE
Jul 2024
MARKETPEEL · /INSIDER/0001918845DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback